Clinical trial
Letrozole Treatment in Normal and GnRH Deficient Women
NCT00351416 · Massachusetts General Hospital, Other · Unknown status
Key facts
| NCT number | NCT00351416 |
|---|---|
| Title | Letrozole Treatment in Normal and GnRH Deficient Women |
| Official title | Letrozole Treatment in Normal and GnRH Deficient Women |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Drug |
| Interventions | Letrozole, NAL-GLU GnRH antagonist |
| Enrollment | 15 |
| Start date | Jan 21, 2004 |
| Primary completion | Jun 29, 2009 |
| First posted | Jul 12, 2006 |
| Last update posted | Jul 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: